Investigational Site Number: 2030003

Ostrava 708 52

2 studies enrolling now · 3 studies all time

What they study most

Hidradenitis Suppurativa, Plasma Cell Myeloma, Type 1 Diabetes Mellitus

Studies at this site

• Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa — Recruiting now
• International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab — Enrolling by invitation
• Frexalimab in Preservation of Endogenous Insulin Secretion Compared to Placebo in Adults, Adolescents and Children on Top of Insulin Therapy (FABULINUS) — Running, not enrolling